These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23627715)

  • 21. Rubella vaccine: new horizon in prevention of congenital rubella syndrome in the India.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2012 Jun; 8(6):831-3. PubMed ID: 22495120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introduction of rubella-containing-vaccine to Madagascar: implications for roll-out and local elimination.
    Wesolowski A; Mensah K; Brook CE; Andrianjafimasy M; Winter A; Buckee CO; Razafindratsimandresy R; Tatem AJ; Heraud JM; Metcalf CJ
    J R Soc Interface; 2016 Apr; 13(117):. PubMed ID: 27122178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2012-2020.
    Zimmerman LA; Knapp JK; Antoni S; Grant GB; Reef SE
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):196-201. PubMed ID: 35143468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2000-2018.
    Grant GB; Desai S; Dumolard L; Kretsinger K; Reef SE
    MMWR Morb Mortal Wkly Rep; 2019 Oct; 68(39):855-859. PubMed ID: 31581161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights from epidemiological game theory into gender-specific vaccination against rubella.
    Shim E; Kochin B; Galvani A
    Math Biosci Eng; 2009 Oct; 6(4):839-54. PubMed ID: 19835431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Rubella Vaccine Introduction on Rubella Infection and Congenital Rubella Syndrome: A Systematic Review of Mathematical Modelling Studies.
    Motaze NV; Mthombothi ZE; Adetokunboh O; Hazelbag CM; Saldarriaga EM; Mbuagbaw L; Wiysonge CS
    Vaccines (Basel); 2021 Jan; 9(2):. PubMed ID: 33503898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The history of rubella and rubella vaccination leading to elimination.
    Plotkin SA
    Clin Infect Dis; 2006 Nov; 43 Suppl 3():S164-8. PubMed ID: 16998777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries.
    Levin A; Burgess C; Shendale S; Morgan W; Cw Hutubessy R; ; Jit M;
    BMJ Glob Health; 2023 Jul; 8(7):. PubMed ID: 37429697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Review of Health Economic Analyses of Measles and Rubella Immunization Interventions.
    Thompson KM; Odahowski CL
    Risk Anal; 2016 Jul; 36(7):1297-314. PubMed ID: 25545778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
    Ferson MJ; Robertson PW; Whybin LR
    Med J Aust; 1994 Apr; 160(8):478-82. PubMed ID: 8170422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New goal for vaccination programs in the Region of the Americas: to eliminate rubella and congenital rubella syndrome. 2003].
    Rev Panam Salud Publica; 2003 Nov; 14(5):359-63. PubMed ID: 14766037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burden of Congenital Rubella Syndrome (CRS) in Bangladesh: Systematic Review of Existing Literature and Transmission Modelling of Seroprevalence Studies.
    Chan J; Wu Y; Wood J; Muhit M; Mahmood MK; Karim T; Moushumi F; Jones CA; Snelling T; Khandaker G
    Infect Disord Drug Targets; 2020; 20(3):284-290. PubMed ID: 30289078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress toward elimination of rubella and congenital rubella syndrome--the Americas, 2003-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(43):1176-9. PubMed ID: 18971920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rubella seroepidemiology and estimations of the catch-up immunisation rate and persistence of antibody titers in pregnant women in Taiwan.
    Lin CC; Yang CY; Shih YL; Hsu HW; Yang TH; Cheng YW; Chang CF; Hsieh LC; Chen BH; Lee CH; Huang YL
    BJOG; 2011 May; 118(6):706-12. PubMed ID: 21385304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress Toward Rubella and Congenital Rubella Syndrome Control - South-East Asia Region, 2000-2016.
    Khanal S; Bahl S; Sharifuzzaman M; Dhongde D; Pattamadilok S; Reef S; Morales M; Dabbagh A; Kretsinger K; Patel M
    MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(21):602-606. PubMed ID: 29851943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress in Italy in control and elimination of measles and congenital rubella.
    Bonanni P; Bechini A; Boccalini S; Peruzzi M; Tiscione E; Boncompagni G; Mannelli F; Salmaso S; Filia A; Ciofi degli Atti M
    Vaccine; 2007 Apr; 25(16):3105-10. PubMed ID: 17306425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rubella vaccination and congenital rubella syndrome in Western Australia.
    Condon RJ; Bower C
    Med J Aust; 1993 Mar; 158(6):379-82. PubMed ID: 8479351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No. 203-Rubella in Pregnancy.
    Dontigny L; Arsenault MY; Martel MJ
    J Obstet Gynaecol Can; 2018 Aug; 40(8):e615-e621. PubMed ID: 30103885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.